BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24581596)

  • 21. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Large Cohort Study of 18F Fluoro-Deoxy-Glucose Uptake in Normal Spinal Cord: Quantitative Assessment of the Contamination From Adjacent Vertebral Marrow Uptake and Validity of Normalizing the Cord Uptake Against the Lumbar Thecal Sac.
    Patel NJ; Gupta V; Vibhute PG; Jain MK; Accurso JM
    J Comput Assist Tomogr; 2017 Jan; 41(1):125-130. PubMed ID: 27560019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI.
    Seraj SM; Al-Zaghal A; Zadeh MZ; Jahangiri P; Pournazari K; Raynor WY; Werner TJ; Høilund-Carlsen PF; Alavi A; Hunt SJ
    Nucl Med Commun; 2019 May; 40(5):545-551. PubMed ID: 30807535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
    Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P
    J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive correlation between serum liver enzyme levels and standard uptake values of liver on FDG-PET.
    Lin CY; Ding HJ; Lin T; Lin CC; Kuo TH; Kao CH
    Clin Imaging; 2010; 34(2):109-12. PubMed ID: 20189073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET.
    Lin CY; Lin WY; Lin CC; Shih CM; Jeng LB; Kao CH
    Clin Imaging; 2011; 35(6):437-41. PubMed ID: 22040787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
    Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
    Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.
    Hong SP; Noh TS; Moon SH; Cho YS; Lee EJ; Choi JY; Kim BT; Lee KH
    Dig Dis Sci; 2014 Mar; 59(3):607-13. PubMed ID: 24326630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of age on FDG uptake in the liver on PET scan.
    Lin CY; Ding HJ; Lin CC; Chen CC; Sun SS; Kao CH
    Clin Imaging; 2010; 34(5):348-50. PubMed ID: 20813297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of blood glucose level on standardized uptake value (SUV) in
    Eskian M; Alavi A; Khorasanizadeh M; Viglianti BL; Jacobsson H; Barwick TD; Meysamie A; Yi SK; Iwano S; Bybel B; Caobelli F; Lococo F; Gea J; Sancho-Muñoz A; Schildt J; Tatcı E; Lapa C; Keramida G; Peters M; Boktor RR; John J; Pitman AG; Mazurek T; Rezaei N
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):224-237. PubMed ID: 30350009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.
    Iozzo P; Jarvisalo MJ; Kiss J; Borra R; Naum GA; Viljanen A; Viljanen T; Gastaldelli A; Buzzigoli E; Guiducci L; Barsotti E; Savunen T; Knuuti J; Haaparanta-Solin M; Ferrannini E; Nuutila P
    Gastroenterology; 2007 Feb; 132(2):531-42. PubMed ID: 17258736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer.
    An YS; Sheen SS; Oh YJ; Hwang SC; Yoon JK
    Ann Nucl Med; 2007 Dec; 21(10):585-92. PubMed ID: 18092135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Kawada H; Noda Y; Moriyama N
    Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.